Results 181 to 190 of about 32,623 (326)

Cutaneous Lupus Erythematosus: Current Treatment Options [PDF]

, 2016
J.K. Presto, Victoria P. Werth
openalex   +1 more source

Specialty‐Based Disparities in Biologic Use and Retention in Psoriatic Arthritis: A Nationwide Korean Claims Analysis

International Journal of Rheumatic Diseases, Volume 29, Issue 7, July 2026.
ABSTRACT Aim Biologic agents play a pivotal role in controlling both articular and cutaneous manifestations of psoriatic arthritis (PsA). Although international guidelines emphasize the appropriate use of biologics, Korea lacks standardized treatment protocols tailored for PsA across specialties.
Bon San Koo, Ye‐Jee Kim, Yeo‐Jin Lee, Yong‐Gil Kim, Tae‐Hwan Kim   +4 more
wiley   +1 more source

Chilblain lupus: A rare form of cutaneous lupus erythematosus - A case report. [PDF]

SAGE Open Med Case Rep
Perazzolli G, Banchetti E, Melis E, Carletto A, Girolomoni G, Gisondi P.   +5 more
europepmc   +1 more source

Severe Cutaneous Eruption in a Woman After Ingesting Multiple Drugs: A Rare Presentation of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-Like Lupus Erythematosus [PDF]

Ahu Yorulmaz, Eylül Ceren Bal Bayazıtlı, Utku ORMAN, Emine Tamer, Huban Sibel Orhun   +4 more
openalex   +1 more source

Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double‐Blind, Randomized, Parallel‐Group Trial [PDF]

, 2016
Naoto Yokogawa, Hitomi Eto, Akiko Tanikawa, Takaharu Ikeda, Kazuhiko Yamamoto, Toshiya Takahashi, Hideya Mizukami, Tomonobu Satô, Naohisa Yokota, Fukumi Furukawa   +9 more
openalex   +1 more source

Thymus and Leishmania at the Crossroads: Autoimmunity and Cancer

Immunology, Volume 178, Issue 3, Page 377-386, July 2026.
Conceptual ‘Crossroads Model’ linking Leishmania, thymic infection and immune dysregulation: an integrative model is proposed in which Leishmania infection disrupts thymic architecture and stromal–thymocyte interactions. These alterations converge to promote defective tolerance, increased autoimmune risk and a microenvironment permissive to malignant ...
Alef Batista Bezerra Barros, Gabriel Augusto Leite, Arthur Gomes de Andrade, Maria Danielma dos Santos Reis, Luiz Henrique Agra Cavalcante‐Silva, Marvin Paulo Lins   +5 more
wiley   +1 more source

An Overview of the Pathogenesis of Cutaneous Lupus Erythematosus. [PDF]

J Clin Med
Verdelli A, Barletta E, Mariotti EB, Landini S, Magnatta A, Ruffo di Calabria V, Corrà A, Quintarelli L, Bonanni I, Sanna L, Corti V, Caproni M.   +11 more
europepmc   +1 more source

ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus

, 1997
To verify (1) how many patients with cutaneous lupus erythematosus (CLE) fulfill 4 or more American Rheumatism Association (ARA) and European Academy of Dermatology and Venereology (EADV) criteria for classification of systemic lupus erythematosus (SLE);
REBORA, ALFREDO, PARODI, AURORA
core  

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page 1137-1161, July 2026.
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda, B. Tedbirt, C. Bodemer, M. C. Bolling, M. El Hachem, M. Nikolić, E. Benton, M. Caproni, D. De, D. Didona, K. Drenovska, M. Goebeler, M. Hertl, B. Horváth, M. Kasperkiewicz, D. Kiritsi, M. Larralde, A. V. Marzano, J. Meijer, D. F. Murrell, J. Powell, E. Sprecher, N. S. Chandran, M. M. Tomayko, S. Uzun, N. van Beek, H. Ott, A. Patsatsi, A. Torrelo, A. Welfringer‐Morin, E. Schmidt, P. Joly   +31 more
wiley   +1 more source

Upregulated GLUT1 expression correlates with type I interferon activity and disease severity in cutaneous lupus erythematosus. [PDF]

J Transl Autoimmun
Bokor LA, Szabolcs BL, Király Z, Mohos A, Szepesi Á, Varga V, Sebestyén A, Kemény LV, Holló P, Hidvégi B.   +9 more
europepmc   +1 more source